Please try another search
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. It has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Michael S. Richman | 61 | 2015 | Co-Founder, CEO, President & Director |
Mario Sznol | 64 | - | Member of Scientific Advisory Board |
Stephen D. Miller | - | - | Member of Scientific Advisory Board |
Stephen W. Webster | 61 | 2019 | Independent Director |
David S. Kabakoff | 74 | 2015 | Independent Chairman of the Board |
Elaine V. Jones | 67 | 2015 | Independent Director |
Lieping Chen | 64 | 2015 | Co-Founder & Chairman of Scientific Advisory Board |
Chau Quang Khuong | 46 | 2015 | Independent Director |
John G. Houston | 63 | 2020 | Independent Director |
Anne Elizabeth Borgman-Hagey | 55 | 2021 | Independent Director |
Weiping Zou | - | 2021 | Member of Scientific Advisory Board |
Ellen Gwen Feigal | 69 | 2021 | Independent Director |
Brahm Segal | - | 2022 | Member of Scientific Advisory Board |
Lisa M. Coussens | - | 2022 | Member of Scientific Advisory Board |
Ursula A. Matulonis | - | 2021 | Member of Scientific Advisory Board |
Rakesh Dixit | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review